Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A Oncogene into Oral Cancer Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Cantini, Liliana ^a   Attaway, Christopher C ^a   Butler, Betsy ^a   Andino, Lourdes M ^a   Sokolosky, Melissa L ^a   Jakymiw, Andrew ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHIMERIC PROTEIN; MESSENGER RNA; OLIGOPEPTIDE; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL TRANSPORT; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG SYNTHESIS; ENDOSOME; FEASIBILITY STUDY; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; ONCOGENE; ONCOGENE CIP2A; PROTEIN METABOLISM; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; RNA BINDING; STATIC ELECTRICITY; TREATMENT OUTCOME; TUMOR INVASION;

ARGININE; AUTOANTIGENS; CELL LINE, TUMOR; GENE SILENCING; HUMANS; MEMBRANE PROTEINS; MOUTH NEOPLASMS; ONCOGENES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84883333001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073348     Document Type: Article

References (45)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, et al. (2008) Surveillance for cancers associated with tobacco use-United States, 1999-2004. MMWR Surveill Summ 57: 1-33.
3. Campana JP, Meyers AD, (2006) The surgical management of oral cancer. Otolaryngol Clin North Am 39: 331-348.
4. Rana TM, (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8: 23-36.
5. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
6. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
7. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ, (2001) Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293: 1146-1150.
8. Rettig GR, Behlke MA, (2012) Progress toward in vivo use of siRNAs-II. Mol Ther 20: 483-512.
9. Zamore PD, Tuschl T, Sharp PA, Bartel DP, (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101: 25-33.
10. Bramsen JB, Kjems J, (2012) Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering. Front Genet 3: 154.
11. Dominska M, Dykxhoorn DM, (2010) Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci 123: 1183-1189.
12. El-Sayed A, Futaki S, Harashima H, (2009) Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. Aaps J 11: 13-22.
13. Jarver P, Coursindel T, Andaloussi SEL, Godfrey C, Wood MJA, et al. (2012) Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA. Molecular Therapy-Nucelic Acids 1: e27.
14. Plank C, Zauner W, Wagner E, (1998) Application of membrane-active peptides for drug and gene delivery across cellular membranes. Adv Drug Deliv Rev 34: 21-35.
15. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E, (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 269: 12918-12924.
16. Oliveira S, van Rooy I, Kranenburg O, Storm G, Schiffelers RM, (2007) Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int J Pharm 331: 211-214.
17. Mastrobattista E, Koning GA, van Bloois L, Filipe AC, Jiskoot W, et al. (2002) Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J Biol Chem 277: 27135-27143.
18. Meade BR, Dowdy SF, (2008) Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 60: 530-536.
19. Wadia JS, Stan RV, Dowdy SF, (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10: 310-315.
20. Lundberg P, El-Andaloussi S, Sutlu T, Johansson H, Langel U, (2007) Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. Faseb J 21: 2664-2671.
21. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, et al. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97: 13003-13008.
22. Kim WJ, Christensen LV, Jo S, Yockman JW, Jeong JH, et al. (2006) Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 14: 343-350.
23. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, et al. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448: 39-43.
24. Bockelman C, Hagstrom J, Makinen LK, Keski-Santti H, Hayry V, et al. (2011) High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br J Cancer 104: 1890-1895.
25. Junttila MR, Puustinen P, Niemela M, Ahola R, Arnold H, et al. (2007) CIP2A inhibits PP2A in human malignancies. Cell 130: 51-62.
26. Katz J, Jakymiw A, Ducksworth MK, Stewart CM, Bhattacharyya I, et al. (2010) CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biol Ther 10: 694-699.
27. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, et al. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278: 585-590.
28. Abramoff MD, Magelhaes PJ, Ram SJ, (2004) Image processing with ImageJ. Biophotonics Int 11: 36-42.
29. Come C, Laine A, Chanrion M, Edgren H, Mattila E, et al. (2009) CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15: 5092-5100.
30. Ren J, Li W, Yan L, Jiao W, Tian S, et al. (2011) Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival. Br J Cancer 105: 1905-1911.
31. Gioanni J, Fischel JL, Lambert JC, Demard F, Mazeau C, et al. (1988) Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 24: 1445-1455.
32. Moschos SA, Jones SW, Perry MM, Williams AE, Erjefalt JS, et al. (2007) Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem 18: 1450-1459.
33. Turner JJ, Jones S, Fabani MM, Ivanova G, Arzumanov AA, et al. (2007) RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Mol Dis 38: 1-7.
34. Jiao CY, Delaroche D, Burlina F, Alves ID, Chassaing G, et al. (2009) Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem 284: 33957-33965.
35. Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hallbrink M, et al. (2011) Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner. Chem Biol 18: 1000-1010.
36. Khalil IA, Futaki S, Niwa M, Baba Y, Kaji N, et al. (2004) Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther 11: 636-644.
37. Claffey DJ, Meyer JD, Beauvais R, Brandt T, Shefter E, et al. (2000) Long chain arginine esters: a new class of cationic detergents for preparation of hydrophobic ion-paired complexes. Biochem Cell Biol 78: 59-65.
38. Furgeson DY, Chan WS, Yockman JW, Kim SW, (2003) Modified linear polyethylenimine-cholesterol conjugates for DNA complexation. Bioconjug Chem 14: 840-847.
39. Yockman JW, Maheshwari A, Han SO, Kim SW, (2003) Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes. J Control Release 87: 177-186.
40. Blessing T, Remy JS, Behr JP, (1998) Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A 95: 1427-1431.
41. Hatakeyama H, Ito E, Akita H, Oishi M, Nagasaki Y, et al. (2009) A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J Control Release 139: 127-132.
42. Rejman J, Oberle V, Zuhorn IS, Hoekstra D, (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377: 159-169.
43. Andaloussi SE, Lehto T, Mager I, Rosenthal-Aizman K, Oprea, II, et al, (2011) Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res 39: 3972-3987.
44. Danhier F, Feron O, Preat V, (2010) To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148: 135-146.
45. Mae M, El Andaloussi S, Lundin P, Oskolkov N, Johansson HJ, et al. (2009) A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. J Control Release 134: 221-227.